- REPL
- REPLIMUNE GROUP INC
-
8.69+4.01 (+85.68%) 05/29 close, EST
- Signals
- Analysis
- Financials
- Charts
- Dividends
AI Signals
Trade Signals
- 3 months
- 6 months
- 1 year
As a biotechnology company, it develops tumor solubility immune gene therapy to treat cancer.